Probiotic Interventions in Gastrointestinal Health

Probiotics—live microorganisms that confer health benefits when consumed in adequate amounts—have emerged as a promising approach to maintain and restore gastrointestinal health. Research over the past decade has underscored their role in balancing the intestinal microbiota, enhancing barrier function and modulating immune responses. These benefits are particularly relevant in contexts of malnutrition, antibiotic‐associated dysbiosis and parasitic infections, where shifts in microbial communities can compromise nutrient absorption, provoke inflammation and increase susceptibility to pathogens. Probiotic strains such as Lactobacillus, Bifidobacterium and Saccharomyces have been shown to produce metabolites—including short‐chain fatty acids and bile‐salt hydrolases—that inhibit pathogens, support epithelial restitution and regulate mucosal immunity. Clinical and preclinical studies indicate that targeted probiotic administration can accelerate recovery from atrophic changes in the gut epithelium, attenuate inflammatory cascades and reduce the severity of infections such as giardiasis. Mechanistic work has illuminated interactions between probiotics and host cells, including reinforcement of tight junctions, stimulation of mucin production and modulation of cytokine profiles, thereby restoring homeostasis within the gut ecosystem. The global significance of these interventions extends from paediatric malnutrition in low‐resource settings to antibiotic stewardship and chronic inflammatory disorders, underscoring the potential of probiotics as adjunctive or preventive therapies in diverse clinical scenarios.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Probiotic Interventions in Gastrointestinal Health publication trend

The graph below shows the total number of articles in probiotic interventions in gastrointestinal health across all publications each year (not limited to Nature Index journals).

Technical terms

Probiotic: Live microorganisms which, when administered in adequate amounts, confer a health benefit on the host by modulating the gut microbiota and host functions.

Dysbiosis: An imbalance in the microbial community structure of the intestine that can lead to impaired digestion, inflammation or susceptibility to infection.

Mucosal barrier integrity: The state of epithelial cell junctions and mucus layers that prevent pathogen translocation and maintain selective permeability in the gut.

Bile‐salt hydrolase: An enzyme produced by certain probiotic bacteria that deconjugates bile acids, influencing lipid metabolism and direct antibacterial activity against pathogens.

References

1. Giardia antagonizes beneficial functions of indigenous and therapeutic intestinal bacteria during protein deficiency. Gut Microbes (2024).
2. The Influence of the Protozoan Giardia lamblia on the Modulation of the Immune System and Alterations in Host Glucose and Lipid Metabolism. International Journal of Molecular Sciences (2024).
3. Deconjugated Bile Salts Produced by Extracellular Bile-Salt Hydrolase-Like Activities from the Probiotic Lactobacillus johnsonii La1 Inhibit Giardia duodenalis In vitro Growth. Frontiers in Microbiology (2016).
4. Probiotics enhance the recovery of gut atrophy in experimental malnutrition.. Biocell (2004).
5. Preventive role of probiotic bacteria against gastrointestinal diseases in mice caused by Giardia lamblia. Bioscience Reports (2021).